Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies

BACKGROUND: Ovarian cancer is the third leading cause of death among gynecological cancers in women in China. Chemotherapy is an important method for comprehensive treatment of ovarian cancer, but the curative effect is poor. PURPOSE: In this study, gemcitabine (GEM) -loaded RGD modified liposomes (...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zhongyuan, Feng, Weiwei, Yang, Yiqing, Wang, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756163/
https://www.ncbi.nlm.nih.gov/pubmed/31571830
http://dx.doi.org/10.2147/DDDT.S211168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756163/
https://www.ncbi.nlm.nih.gov/pubmed/31571830
http://dx.doi.org/10.2147/DDDT.S211168

Ejemplares similares